Abnormality in glucose tolerance appears to correlate with arteriosclerotic disease, even when the abnormality is quite mild. Though there is no evidence for prevention of these vascular problems by correction of the carbohydrate abnormality, it seems reasonable to attempt such a correction in an investigational setting. We have used sulfonylurea (tolbutamide, chlorpropamide) in children and young adults (935 yr) without obesity, who have chemical diabetes. No apparent effect on insulin output has been noted, even with normalization of glucose tolerance.
B
EFORE DISCUSSING the use of sulfonylurea compounds in the treatment of chemical diabetes, we must ask ourselves whether there is any evidence to indicate that mild carbohydrate intolerance may be harmful. Although this is a controversial question, there is some evidence that this may be true. There are four studies which give epidemiologic evidence. One is the Tecumsah, Michigan study. Dr. Ostrander, Dr. Epstein, and colleagues have shown that there is an excellent correlation between elevated blood sugar levels and the prevalence of coronary artery disease and generally of arteriosclerotic vascular disease.l*" This does not establish a cause and effect relationship necessarily, but it does establish a very strong correlation. Another epidemiologic study is the Bedford study, published by Keen et a1.3*4 Individuals with chemical diabetes as well as those with what was termed "borderline diabetes" were compared with control subjects. "Borderline diabetics," by this definition, are individuals who had venous whole blood sugar levels between 120 and 200 mg/100 ml 2 hr after a 50-g carbohydrate load. In these groups there was a correlation between blood sugar levels and the incidence of arterial disease. In addition to epidemiologic studies, there are studies of patients with arteriosclerotic heart disease. One study involved patients (mean age 46 yr) with coronary artery disease established by angiography.5 Abnormality of carbohydrate tolerance was found in 64% of those patients; abnormal lipid levels existed in about 51% of those patients. 6 Combining both sets of observations, about 85% of all the patients with coronary heart disease had one or the other of these metabolic abnormalities. In another study of patients with coronary artery disease established by coronary arteriography, there was a 63% incidence of an abnormality of glucose tolerance, while 74% of the patients had an elevation of serum lipids. 
